0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to

Sainath Raman1,2, Andreas Schibler3,4, Renate Le Marsney3

  • 1Paediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland, 62 Graham Street, South Brisbane, QLD, 4101, Australia. sainath.raman@uq.edu.au.

Trials
|July 4, 2021
PubMed

Insights

This study compared balanced intravenous fluids to normal saline in critically ill children. Balanced solutions may reduce the risk of hyperchloremia, a complication associated with normal saline.

Area of Science:

  • Critical Care Medicine
  • Pediatric Critical Care
  • Intravenous Fluid Therapy

Background:

  • Intravenous fluid therapy is a common intervention for critically ill patients.
  • 0.9% sodium chloride (normal saline) is associated with hyperchloremia and worse outcomes.
  • Evidence on optimal fluid choices in critically ill children is limited.

Purpose of the Study:

  • To evaluate if balanced solutions reduce the incidence of increased serum chloride levels compared to 0.9% sodium chloride in critically ill children.
  • To compare the risk of hyperchloremia associated with normal saline versus balanced solutions in pediatric intensive care.

Main Methods:

  • Single-centre, open-label randomized controlled trial with 1:1:1 assignment.
  • Three groups: 0.9% sodium chloride, Plasma-Lyte 148, and Compound Sodium Lactate.
  • Primary outcome: ≥ 5mmol/L increase in serum chloride within 48 hours; 480 patients enrolled; intention-to-treat analysis.

Main Results:

  • This section is not available in the provided abstract.

Conclusions:

  • This pragmatic study assesses a common intervention in pediatric critical care.
  • It compares normal saline to balanced solutions for intravenous fluid therapy.
  • Exclusions include pediatric patients with cardiac conditions or traumatic brain injury.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
63
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
64
Composition of Body Fluids01:29

Composition of Body Fluids

Water functions as a solvent accommodating various solutes, which can be categorized under electrolytes and non-electrolytes. Non-electrolytes are usually held together by covalent bonds, restricting them from dissociating in solution, thereby leading to a lack of electrically charged components upon dissolving in water. They are predominantly organic molecules, such as glucose, creatinine, and urea. Electrolytes, on the other hand, are compounds that can break down into ions in water.
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50